Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03929809 · ClinicalTrials.gov registry record
Iowa Cochlear Implant Clinical Research Center Study of SSD Using Med-El Cochlear Implants
A clinical trial, sponsored by University of Iowa.
- Completed
- Registry status
- 10
- Enrollment target
NCT03929809: Completed study, sponsored by University of Iowa.
NCT03929809 is a clinical trial that has completed, run by University of Iowa. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03929809 has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to understand the speech perception in noise and in quiet and localization benefits in a laboratory setting in listeners that receive a cochlear implant in an ear with severe to profound hearing loss and have normal, or near-normal hearing in the opposite ear. We will also evaluate the functional benefit of restoring hearing to the impaired ear via questionnaires that subjects will be answering while listening in their natural environment.
Primary Outcome
The percent correct of words from a list of 20 Target AzBio sentences will be played from 0° azimuth. A list of AzBio sentences will be played in multitalker babble which will be presented in three different conditions: 0° azimuth, S0N90, or S0N270°.
Interventions
- DEVICE Cochlear Implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-06-20 |
| Est. Completion | 2021-08-18 |
What the finished NCT03929809 record still lists
NCT03929809 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Cochlear Implant is the first listed.
NCT03929809 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03929809 about?
NCT03929809 is a clinical study titled "Iowa Cochlear Implant Clinical Research Center Study of SSD Using Med-El Cochlear Implants". The purpose of this study is to understand the speech perception in noise and in quiet and localization benefits in a laboratory setting in listeners that receive a cochlear implant in an ear with severe to profound hearing loss and have normal, or near-normal hearing in the opposite ear. We will al...
What is the current status of trial NCT03929809?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2019-06-20. Estimated completion is 2021-08-18.
What interventions are being tested in trial NCT03929809?
The interventions under investigation include: Cochlear Implant (DEVICE).
Who is sponsoring clinical trial NCT03929809?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI